Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Daiichi Sankyo
Cipla
Julphar
Fish and Richardson
Argus Health
Moodys
Dow
Chinese Patent Office

Generated: May 25, 2018

DrugPatentWatch Database Preview

Tripelennamine hydrochloride - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for tripelennamine hydrochloride and what is the scope of tripelennamine hydrochloride patent protection?

Tripelennamine hydrochloride
is the generic ingredient in three branded drugs marketed by Novartis, Anabolic, Barr, Heather, Impax Labs, Lannett, Nylos, Parke Davis, and Watson Labs, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for tripelennamine hydrochloride.
Summary for tripelennamine hydrochloride
US Patents:0
Tradenames:3
Applicants:9
NDAs:14
Drug Master File Entries: 1
Bulk Api Vendors: 51
Patent Applications: 869
DailyMed Link:tripelennamine hydrochloride at DailyMed
Synonyms for tripelennamine hydrochloride
1, N,N-dimethyl-N'-(phenylmethyl)-N'-2-pyridinyl-, monohydrochloride
1,2-Ethanediamine, N,N-dimethyl-N'-(phenylmethyl)-N'-2-pyridinyl-, hydrochloride
1,2-Ethanediamine, N,N-dimethyl-N'-(phenylmethyl)-N'-2-pyridinyl-, monohydrochloride
1,2-Ethanediamine, N1,N1-dimethyl-N2-(phenylmethyl)-N2-2-pyridinyl-, hydrochloride (1:?)
154-69-8
2-(benzyl(2-(dimethylamino)ethyl)amino)-pyridinhydrochloride
2-(Benzyl(2-(dimethylamino)ethyl)amino)pyridine hydrochloride
2-(Benzyl(2-(dimethylamino)ethyl)amino)pyridine monohydrochloride
2-[Benzyl(2-dimethylamino- ethyl)amino]pyridine
2-[Benzyl(2-dimethylamino-ethyl)amino]pyridine
2-[Benzyl[2-(dimethylamino)ethyl]amino]pyridine hydrochloride
22306-05-4
91-81-6 (Parent)
A809564
AC1L1S8S
Ahistamin
AK128962
AKOS015913800
AntiAllergicum Medivet
C16H21N3.HCl
CCG-100816
CCRIS 1969
CHEMBL1200446
CPD000058623
CS-1395
CTK8G3630
D02091
Dehistin monohydrochloride
DTXSID6026248
EINECS 205-833-5
Ethylenediamine, N-benzyl-N',N'-dimethyl-N-(2-pyridyl)-, hydrochloride
Ethylenediamine,N'-dimethyl-N-(2-pyridyl)-, hydrochloride
FSSICIQKZGUEAE-UHFFFAOYSA-N
FT-0631854
FWV8GJ56ZN
HE058800
HY-17428
I14-45121
KB-258517
KS-00000I5Z
LS-173945
LS-889
MCULE-1458594447
MFCD00012815
MLS000069522
MLS000758254
MLS001148406
MLS001423999
MolPort-003-894-746
N-[Benzyl-N-(dimethylamino)ethyl] .alpha.-aminopyridine hydrochloride
N-Benzyl-N-.alpha.-pyridyl-N',N'-dimethyl-aethylendiamin-hydrochlorid
N-benzyl-N-[2-(dimethylamino)ethyl]pyridin-2-amine hydrochloride
N-Benzyl-N-alpha-pyridyl-N',N'-dimethyl-aethylendiamin-hydrochlorid
N-Benzyl-N-alpha-pyridyl-N',N'-dimethyl-aethylendiamin-hydrochlorid [German]
N-Benzyl-N-dimethylaminoethyl alpha-aminopyridine hydrochloride
N-Benzyl-N',N'-dimethyl-N-2-pyridyl-ethylenediamine hydrochloride
N-benzyl-N',N'-dimethyl-N-pyridin-2-ylethane-1,2-diamine hydrochloride
N,N-Dimethyl-N'-(2-pyridyl)-N'-benzylethylenediamine hydrochloride
N,N-dimethyl-N'-(phenylmethyl)-N'-(2-pyridinyl)ethane-1,2-diamine hydrochloride
N,N-dimethyl-N'-(phenylmethyl)-N'-pyridin-2-yl-ethane-1,2-diamine hydrochloride
N'-benzyl-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine hydrochloride
N'-benzyl-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine;hydrochloride
N(sup 1)-.alpha.-Pyridyl-N(sup 1)-benzyl-N,N-dimethyl ethylenediamine monohydrochloride
N(sup 1)-alpha-Pyridyl-N(sup 1)-benzyl-N,N-dimethyl ethylenediamine monohydrochloride
N~1~-benzyl-N~2~,N~2~-dimethyl-N~1~-(2-pyridinyl)-1,2-ethanediamine hydrochloride
N1-Benzyl-N2,N2-dimethyl-N1-(pyridin-2-yl)ethane-1,2-diamine hydrochloride
NC00066
NIH 10186
NSC 409943
NSC-409943
NSC409943
Opera_ID_1597
Pbz-Sr
PBZ-SR (TN)
Piristin
Pyrabenzamine
Pyribenzamine hydrochloride
Pyribenzamine monohydrochloride
Pyridine, 2-(benzyl(2-(dimethylamino)ethyl)amino)-, hydrochloride
Pyridine, 2-(benzyl(2-(dimethylamino)ethyl)amino)-, monohydrochloride
Pyrinamine
Pyristine (pristina) hydrochloride
Re-Covr Injectable (Veterinary)
ReCovr
s3146
SAM001247047
SC-94044
SCHEMBL98916
SMR000058623
SR-01000003013
SR-01000003013-7
ST24050293
ST50411553
Stanzamine
Tri-Tumine
Tripelannamine hydrochloride
Tripelenamine hydrochloride
Tripelennamine (hydrochloride)
Tripelennamine chloride
Tripelennamine Hcl
TRIPELENNAMINE HYDROCHLORIDE (SEE ALSO: TRIPELENNAMINE (CAS RN 91-81-6))
Tripelennamine hydrochloride (USP)
Tripelennamine hydrochloride [USAN]
Tripelennamine hydrochloride, analytical standard
Tripelennamine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Tripelennamine monohydrochloride
UNII-FWV8GJ56ZN
W-108029
W-5042
WLN: T6NJ BN1R & 2N1 & 1 & GH
Z1552027600

US Patents and Regulatory Information for tripelennamine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs TRIPELENNAMINE HYDROCHLORIDE tripelennamine hydrochloride TABLET;ORAL 080713-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Anabolic TRIPELENNAMINE HYDROCHLORIDE tripelennamine hydrochloride TABLET;ORAL 083037-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs TRIPELENNAMINE HYDROCHLORIDE tripelennamine hydrochloride TABLET;ORAL 085188-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis PBZ tripelennamine hydrochloride TABLET;ORAL 083149-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Julphar
Cipla
AstraZeneca
Teva
Federal Trade Commission
Fish and Richardson
Chinese Patent Office
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.